Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

RF-1051 receives orphan drug status in PWS

May 24, 1996

Amgen begins clinical testing of leptin

May 24, 1996

Intrachol receives U.S. patent protection

May 24, 1996

Orphan Medical discontinues glucaric acid development

May 24, 1996

Zoledronate effective in Paget's disease patients

May 24, 1996

Ibandronate demonstrates bone-preserving effects in phase II

May 24, 1996

Ortho claims agents for osteoporosis

May 24, 1996

Akzo Nobel claims contraceptive vaccines

May 17, 1996

RPR, Novo Nordisk form global HRT alliance

May 17, 1996

Yamanouchi claims antidiabetic agents

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...